Results 21 to 30 of about 303,740 (263)

The dominant left ventricular assist device: lessons from an era

ESC Heart Failure, 2021
The production and distribution of the HeartWare ventricular assist device has come to an abrupt end, but with this end comes the opportunity to reflect upon lessons learned from its lifespan.
Amit Alam, Gregory P. Milligan, Timothy Gong   +2 more
doaj   +1 more source

Transendocardial CD34 Cell Transplantation in Noncompaction Cardiomyopathy

Cell Transplantation, 2018
Noncompaction cardiomyopathy is a rare congenital heart disorder characterized by an arrest of the myocardial compaction process. This results in the altered formation of coronary microvessels with a resulting decrease in myocardial perfusion ...
Andraz Cerar, Gregor Zemljic, Sabina Frljak, Martina Jaklic, Gregor Poglajen, Matjaz Sever, Marko Cukjati, Bojan Vrtovec   +7 more
doaj   +1 more source

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy

Journal of Cardiovascular Development and Disease, 2022
Aims: Non-ischaemic dilated cardiomyopathy (NIDCM) is characterized by left ventricular (LV) chamber enlargement and systolic dysfunction in the absence of coronary artery disease.
Carles Díez-López, Joel Salazar-Mendiguchía, Elena García-Romero, Lara Fuentes, Josep Lupón, Antoni Bayés-Genis, Nicolás Manito, Marta de Antonio, Pedro Moliner, Elisabet Zamora, Pablo Catalá-Ruiz, Miguel Caínzos-Achirica, Josep Comín-Colet, José González-Costello   +13 more
doaj   +1 more source

Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021
Pulmonary hypertension (PH) has been described in myeloproliferative disorders; monoclonal plasma cell disorder such as polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome; and plasma cell dyscrasias such as ...
Indranee Rajapreyar, MD, Joanna Joly, MD, Jose Tallaj, MD, Salpy V. Pamboukian, MD, Ayman Haj Assad, MD, Carrie Lenneman, MD, Silvio Litovsky, MD, Arka Chatterjee, MD, Charles Hoopes, MD, Andrew Lenneman, MD   +9 more
doaj   +1 more source

Management of Advanced Heart Failure [PDF]

Circulation, 2011
Case presentation: A 65-year-old man with idiopathic dilated cardiomyopathy is referred to an advanced heart failure center for heart transplant evaluation. He presented with decompensated heart failure 2 years earlier. At that time, an echocardiogram demonstrated a left ventricular ejection fraction of 25% with a left ventricular end-diastolic ...
Michelle M, Kittleson, Jon A, Kobashigawa   +1 more
openaire   +2 more sources

Impella 5.5 in left ventricular noncompaction syndrome as bridge to heart transplant

JHLT Open
Background: Left ventricular non-compaction syndrome (LVNC) is an uncommon congenital disease characterized by prominent trabeculations and deep inter-trabecular recesses of the left ventricle wall.
Shriya Sharma, Jose Ruiz, Pankaj Garg, Juan Leoni, Parag Patel, Jose Nativi, Melissa Lyle, Rohan Goswami   +7 more
doaj   +1 more source

Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure

Stem Cells International, 2018
Aim of the Review. The aim of this review is to discuss recent advances in clinical aspects of stem cell therapy in chronic nonischemic heart failure (DCMP) with emphasis on patient selection, stem cell types, and delivery methods.
Gregor Poglajen, Gregor Zemljič, Sabina Frljak, Andraž Cerar, Vesna Andročec, Matjaž Sever, Peter Černelč   +6 more
doaj   +1 more source

Single Center Experience With Impella 5.5 for Escalation and De-Escalation of Cardiogenic Shock Patients

Journal of Interventional Cardiology
Temporary mechanical circulatory support (tMCS) devices are a critical component for treating patients with cardiogenic shock (CS). We analyzed use of Impella 5.5 device for efficacy and safety in a single-center CS population from February 2022 and ...
Ioana Dumitru, Debbie Rinde-Hoffman, Maria Sevillano, Leeandra Schnell, Elizabeth Quintilliani, Swaroop Bommareddi   +5 more
doaj   +1 more source

Prevalence of 21 Physician‐Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier, Brittany Grantham, Camilla Grud Nielsen, Louise Lundgren, Liv Andrés‐Jensen, Kjeld Schmiegelow, Chris Selman, Gareth Ball, Elyse Passmore, David A. Elliott, Rachel Conyers   +10 more
wiley   +1 more source

MAD or MADness?

Cardiovascular Ultrasound
Mitral valve prolapse (MVP) is a common condition affecting approximately 3% of the population, typically with a benign clinical course. However, a small subset of patients (5–10%) may develop severe mitral regurgitation or arrhythmias, which can lead to
Francesco Fulvio Faletra, Giuseppe Sgarito, Francesca Parisi, Eluisa La Franca, Massimiliano Mulè, Alessandra Carvelli, Giovanni Di Stefano, Rita Laura Borrello, Vincenzo Nuzzi, Paolo Manca, Manlio Cipriani   +10 more
doaj   +1 more source